Lifescan Inc., a wholly owned subsidiary of Johnson & Johnson, will pay claims of as many as 200,000 diabetic class members whose lawyers say the company’s blood glucose monitoring system had two potentially life-threatening design defects.

Monday’s settlement comes on top of $60 million in civil and criminal fines leveled against the company in separate suits last December.